News

Diplomat employees use coupons to collect food, toiletries for charity

BY Alaric DeArment

FLINT, Mich. — Diplomat Specialty Pharmacy recently took "extreme couponing" to a new level, not to save money for customers, but to collect items for charity.

Diplomat sponsored a contest in which 12 employees competed to see who could buy the most food items and toiletries for local charities using only $25 and coupons. With $300, employees bought $2,160 worth of groceries, which will be donated to Flint, Mich.-based Carriage Town Ministries and St. Luke N.E.W. Life Center.

"The initial inspiration for the coupling contest came after a visit to the St. Luke N.E.W. Life Center," Diplomat director of enterprise technology resources Michelle West said. "A Diplomat employee, Stephanie Howes, saw their need and came up with ‘extreme couponing’ for a cause, advancing the idea from the popular TV show on TLC."

 

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

News

Onion Crunch beefs up the taste of burgers

BY Jason Owen

NEW YORK — Loeb’s has launched a new condiment topping that is the only kosher pareve and vegan crunchy onion topping available on store shelves, the company said.

Loeb’s Onion Crunch is made from fresh, specially-selected sweet onions that are lightly fried in vegetable oil and seasoned to deliver a roasted onion flavor to anything it is added. Onion Crunch is made with real onions and only four ingredients, and has no added sugars. According to Loeb’s, crsipy onions are already a popular topping in Europe for burgers.

Onion Crunch is available in four flavors: Original, Bacon, BBQ and Chipotle. It can be found on retail shelves next to kethcup and mustard in the condiment aisle at Walmart, Costco, Duane Reade, Safeway, Giant Food Stores and many more.


Like this story? Find us on Facebook for more insight, analysis and the latest in drug store news. Join the conversation.

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

News

Drug for rare, fatal genetic disorder receives FDA approval

BY Alaric DeArment

SILVER SPRING, Md. — The Food and Drug Administration has approved a new treatment for a genetic disorder that affects about 500 people in the United States and 3,000 worldwide, the agency said Tuesday.

The FDA announced the approval of Procysbi (cysteamine bitartrate) delayed-release capsules, made by Novato, Calif.-based Raptor Pharmaceuticals, for cystinosis. Cystinosis causes buildup in every cell of the body of a protein building block called cystine, which can cause kidney problems and thus lead to excess loss of sugar, proteins and salts through the urine. Cystinosis may lead to slow body growth and small stature, weak bones and kidney failure and is fatal if not treated in early childhood. The most severe of the three types of the disease is nephropathic cystinosis, which causes severe kidney damage.

The FDA has approved two other drugs for cystinosis: Mylan’s Cystagon (cysteamine bitartrate), approved in 1994; and Sigma-Tau Pharmaceuticals’ Cystaran (cysteamine) ophthalmic solution eye drops, used to treat corneal cystine crystal accumulation, approved last year.

 

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES